Lv43
722 积分 2023-08-20 加入
Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of life
4天前
已完结
Real‐world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus
6天前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
11天前
已完结
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
20天前
已完结
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
20天前
已完结
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials
20天前
已完结
Hepatic glucagon action: beyond glucose mobilization
28天前
已完结
The role of oral semaglutide in managing type 2 diabetes in Indian clinical settings: Addressing the unmet needs
1个月前
已完结
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
1个月前
已完结
"Unmet needs" in der Therapie des Diabetes mellitus Typ 2
1个月前
已完结
皖公网安备34019202002308
